Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
latanoprost (xalatan) (1 trial)
Glaucoma (Phase 2)
Glaucoma, Open-Angle (Phase 2)
Hypertension (Phase 2)
Ocular Hypertension (Phase 2)
Trials (1 total)
Trial APIs (1 total)